QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

RDNT

QT63RadNet, Inc.
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
53.74
+0.92+1.74%
OverviewShort InterestFilings
RDNTQT63RadNet, Inc.·NASDAQ
OverviewShort InterestFilings
53.74+1.74%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E-EPS (ttm)-0.18
Insider Own10.62%
Shs Outstand78.63M
Perf Week-7.66%
Market Cap4.15BForward P/E56.97EPS next Y0.94Insider Trans0.07%Shs Float-Perf Month0.73%
Enterprise Value5.63BPEG-EPS next Q0.18Inst Own-Short Float-Perf Quarter-14.21%
Income-14537105.00P/S1.94EPS this Y386.51%Inst Trans-Short Ratio-Perf Half Y-24.54%
Sales2.14BP/B3.77EPS next Y82.92%ROA-0.37%Short Interest-Perf YTD-24.68%
Book/sh17.21P/C11.64EPS next 5Y53.65%ROE-1.36%52W High85.85 -37.40%Perf Year-4.99%
Cash/sh5.79P/FCF-EPS past 3/5Y-ROIC1.68%52W Low50.76 5.87%Perf 3Y-
Dividend Est.-EV/EBITDA17.38Sales past 3/5Y12.57% 13.73%Gross Margin9.38%Volatility4.69% 3.24%Perf 5Y-
Dividend TTM-EV/Sales2.63EPS Y/Y TTM1129.95%Oper. Margin3.84%ATR (14)2.89Perf 10Y-
Dividend Ex-Date-Quick Ratio1.17Sales Y/Y TTM17.21%Profit Margin-0.66%RSI (14)44.81Recom1.75
Dividend Gr. 3/5Y-Current Ratio1.17EPS Q/Q20.00%SMA20-2.06%Beta1.23Target Price85.00
Payout0.00%Debt/Eq1.79Sales Q/Q22.29%SMA50-3.96%Rel Volume2.97Prev Close52.82
Employees11,000LT Debt/Eq1.31EarningsAug 10SMA200-21.35%Avg Volume848.57KPrice53.74
IPO DateJan 03, 1997Option/ShortYes / YesEPS/Sales Surpr.-100.00% 3.23%Net Debt/EBITDA4.56Volume2,522,407Change1.74%
Analyst Ratings
DateActionAnalystRatingTarget
May-20-26ReiteratedBarclaysOverweight$79 → $65
Mar-03-26ReiteratedJefferiesBuy$100 → $91
Jan-09-26InitiatedKeyBancOverweight$92
Jan-08-26InitiatedKeyBancOverweight$92
Dec-17-25ReiteratedTruist Financial$81 → $90
Nov-14-25ReiteratedRaymond JamesStrong Buy$95
Sep-03-25ReiteratedTruist Financial$74 → $81
Jul-10-25ReiteratedTruist Financial$88 → $74
Mar-05-25UpgradeRaymond JamesOutperform → Strong Buy
Jan-22-25ReiteratedTruist Financial$94 → $88
Latest News
Jun-10-26
Jun-10-2606:08AM
Radnet Unit DeepHealth Launches Reporting Pro, An AI-Powered Tool For Generating Clinical ReportsBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,1452,0401,830
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,9431,9491,581
Gross Profit20191249
Selling, General and Administrative Excl. Other
000
Research and Development
000
Other Operating Expense1190144
Operating Income8391105
Interest Expense707080
Unusual Expense
———
Non-Operating Income (Expense)-20-11-20
Net Income Before Taxes323245
Income Taxes10156
Consolidated Net Income-15-193
Net Income From Continuing Operations221739
Net Income-15-193
EPS (Recurring)-0.18-0.250.04
EPS (Basic, Before Extraordinaries)-0.18-0.250.04
EPS (Diluted)-0.18-0.250.04
EBITDA324254263
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.932.62—
Gross Margin9.374.4613.61
Operating Margin3.874.465.74
Net Margin-0.70-0.930.16
Shares Outstanding777573
Market Capitalization4,1385,351—
Operating Lease Expense
———
Insider Trading Volume
$65.16$57.32$49.47$41.63$33.79● Close Price0.00M1.51M3.02M4.53M6.05MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Forthuber Stephen MPres & CEO-Eastern OperationsJun 15 '26Sale58.1644,0672,562,911507,199Jun 16 12:00 AM
Berger Howard GPresident, CEOMay 05 '26Option Exercise18.6451,984968,982498,405May 06 12:00 AM
Sorensen Alma GregoryChief Strategy OfficerMar 19 '26Sale62.2015,000933,0141,208,923Mar 23 12:00 AM
Sorensen Alma GregoryChief Strategy OfficerMar 18 '26Sale62.1515,000932,2801,223,923Mar 18 12:00 AM
Sorensen Alma GregoryChief Strategy OfficerMar 10 '26Option Exercise0.0079,79501,244,842Mar 12 12:00 AM
STOLPER MARKEVP, Chief Financial OfficerDec 10 '25Option Exercise6.0771,406433,434103,715Dec 12 12:00 AM
Katz David JeffreyEVP and Chief Legal OfficerDec 10 '25Option Exercise29.446,792199,95671,577Dec 12 12:00 AM
Forthuber Stephen MPres & COO-Eastern OperationsDec 05 '25Sale78.3345,0883,531,849529,221Dec 09 12:00 AM
Forthuber Stephen MPres & COO-Eastern OperationsDec 03 '25Option Exercise6.0778,254475,002574,309Dec 03 12:00 AM
Berger Howard GPresident, CEONov 19 '25Option Exercise18.64259,9224,844,946348,412Nov 21 12:00 AM
Patel MitalEVP of Fin Planning, CAONov 19 '25Sale80.0515,0801,207,154180,138Nov 19 12:00 AM
Patel MitalEVP of Fin Planning, CAONov 18 '25Sale80.009,920793,600195,218Nov 19 12:00 AM
Patel MitalEVP of Fin Planning, CAONov 17 '25Sale76.0625,0001,901,500205,138Nov 19 12:00 AM
STOLPER MARKEVP, Chief Financial OfficerSep 16 '25Sale73.8935,0002,586,15068,012Sep 18 12:00 AM
Katz David JeffreyEVP and Chief Legal OfficerSep 16 '25Sale74.4414,0001,042,16068,181Sep 17 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR